NEW YORK, March 30 (GenomeWeb News) - Shares in Illumina were up 16.76 percent, or $1.17, at $8.15 in mid-afternoon trading after Robert W. Baird upgraded the company's stock to "outperform" from "neutral."
Registering provides access to this and other free content.
Already have an account?Login Now.
The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.
Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.
In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.
Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.